Wordt geladen...
Preclinical immunogenicity and safety of a Group A streptococcal M protein-based vaccine candidate
Streptococcus pyogenes (group A streptococcus, GAS) causes a wide range of clinical manifestations ranging from mild self-limiting pyoderma to invasive diseases such as sepsis. Also of concern are the post-infectious immune-mediated diseases including rheumatic heart disease. The development of a va...
Bewaard in:
| Gepubliceerd in: | Hum Vaccin Immunother |
|---|---|
| Hoofdauteurs: | , , , , , , , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Taylor & Francis
2016
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5215552/ https://ncbi.nlm.nih.gov/pubmed/27541593 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/21645515.2016.1222999 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|